A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders

Proteomics testing provide a lower-cost option and wider application compared to respiratory chain enzymology for mitochondrial disorders and potentially other functional assays in Australia. Our analysis suggests that streamlining and automating workflows can reduce labor costs. Using PBMC samples may be a cheaper and more efficient alternative to generating fibroblasts, although their use has not been extensively tested yet. Use of fibroblasts could potentially lower costs when fibroblasts are already available by avoiding the expense of isolating PBMCs. A joint evaluation of the health and economic implications of proteomics is now needed to support its introduction to routine clinical care.

Authors

Institutions

Publication Details

Journal
Orphanet Journal of Rare Diseases
Published
2024-11-29
DOI
https://doi.org/10.1186/s13023-024-03462-w
Citations
6
Primary Topic
Advanced Proteomics Techniques and Applications
Type
article
Field-Weighted Citation Impact
1.44

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders

David A. Stroud, Ilias Goranitis, John Christodoulou, David R. Thorburn et al.
6 citations
Orphanet Journal of Rare Diseases
Advanced Proteomics Techniques and Applications
1.44
article

A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders

David A. Stroud, Ilias Goranitis, John Christodoulou, David R. Thorburn, Nicholas A. Williamson, Ching‐Seng Ang, Dylan Mordaunt, Francisco Santos Gonzalez, Daniella H. Hock
article en
6 citations

Abstract

Proteomics testing provide a lower-cost option and wider application compared to respiratory chain enzymology for mitochondrial disorders and potentially other functional assays in Australia. Our analysis suggests that streamlining and automating workflows can reduce labor costs. Using PBMC samples may be a cheaper and more efficient alternative to generating fibroblasts, although their use has not been extensively tested yet. Use of fibroblasts could potentially lower costs when fibroblasts are already available by avoiding the expense of isolating PBMCs. A joint evaluation of the health and economic implications of proteomics is now needed to support its introduction to routine clinical care.

Orphanet Journal of Rare DiseasesVol. 19(1)
Royal Children's Hospital (AU), The University of Melbourne (AU), Victorian Clinical Genetics Services (AU), Murdoch Children's Research Institute (AU), Melbourne Health (AU), Melbourne Genomics Health Alliance (AU), Victoria University (AU)
Department of Health and Aged Care, Australian Government, Melbourne Research, University of Melbourne
Decent work and economic growth
Openalex Percentile: Top 19%
Advanced Proteomics Techniques and Applications
1.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.